Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin lispro biphasic (recombinant human insulin analogue) 50/50 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 15/85 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane human 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
opløseligt bovint insulin 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin soluble porcine 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 20/80 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane porcine 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
bovint insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 40/60 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin soluble human 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin soluble porcine 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
bovin isofaninsulin 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin soluble human 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic porcine 30/70 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin soluble human 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
blandet humant insulin zink suspension, 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
insulin glargin (rekombinant human insulinanalog) 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 15/85 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin lispro biphasic (recombinant human insulin analogue) 25/75 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin aspart (recombinant human insulin analogue) 100units/ml inject |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
opløseligt bovint insulin 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Pork insulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin aspart 100units/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
bifasisk insulin aspart 30/70 100 enheder/ml injektionsvæske, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
bifasisk insulin aspart 30/70 100 enheder/ml injektionsvæske i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Human isophane insulin 100units/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Product containing insulin glulisine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Product containing insulin lispro and insulin lispro protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
isofaninsulin NPH + rekombinant human insulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Product containing isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
insulin isofan NPH |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
insulin glulisin 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin human 100units/mL buffered regular solution injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
fiskeinsulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Product containing insulin detemir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin detemir 100iu/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin detemir 100iu/mL injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Insulin |
Is a |
True |
Pancreatic hormone |
Inferred relationship |
Some |
|
Amylin (substance) |
Is a |
True |
Pancreatic hormone |
Inferred relationship |
Some |
|
Product containing amylin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Product containing pramlintide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
pramlintid 0,6 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Free insulin |
Is a |
False |
Pancreatic hormone |
Inferred relationship |
Some |
|
Recombinant human glucagon (substance) |
Is a |
True |
Pancreatic hormone |
Inferred relationship |
Some |
|